Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ORITAVANCIN vs ORLISTAT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ORITAVANCIN vs ORLISTAT: Safety Overview

Metric ORITAVANCIN ORLISTAT
Total FAERS Reports 884 6,498
Deaths Reported 29 31
Death Rate 3.3% 0.5%
Hospitalizations 157 329
Average Patient Age 55.9 yrs 49.0 yrs
% Female Patients 52.2% 83.9%
FDA Approval Date N/A Apr 23, 1999
Manufacturer Melinta Therapeutics, LLC H2-Pharma LLC
Route INTRAVENOUS ORAL
Marketing Status N/A Prescription